Showing 2011-2020 of 2314 results for "".
- Santen Launches Ducressa Post-Cataract Surgery Antibiotic/Steroid Combinationhttps://modernod.com/news/santen-launches-ducressa-post-cataract-surgery-antibiotic-steroid-combination/2478828/Santen EMEA has announced the launch of Ducressa, a fixed dose combination of levofloxacin/dexamethasone eye drops solution indicated for the prevention and treatment of inflammation, and the prevention of infection a
- States ‘Need More Supply’ of COVID-19 Vaccine Amid Push to Grant More Shotshttps://modernod.com/news/states-need-more-supply-of-covid-19-vaccine-amid-push-to-grant-more-shots/2478827/Several states told a congressional panel Tuesday that they have the capacity to dole out thousands more vaccines than they have been getting from the federal government, according to a FierceHealthcare
- Researchers Use Patients’ Cells to Test Gene Therapy for a Form of Leber Congenital Amauroshttps://modernod.com/news/researchers-use-patients-cells-to-test-gene-therapy-for-a-form-of-leber-congenital-amauros/2478810/Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are ch
- Optomed Establishes a Scientific Advisory Boardhttps://modernod.com/news/optomed-establishes-a-scientific-advisory-board/2478806/Optomed announced it is establishing an international scientific advisory board consisting of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmi
- Surface Ophthalmics Announces Positive Topline Results From Phase 2 Trial for SURF-201 for the Treatment of Post-Cataract Surgery Pain and Inflammationhttps://modernod.com/news/surface-ophthalmics-announces-positive-topline-results-from-phase-2-trial-for-surf-201-for-the-treatment-of-post-cataract-surgery-pain-and-inflammation/2478781/Surface Ophthalmics announced positive topline results from the phase 2 trial for SURF-201, an investigational therapy for the treatment of post-cataract surgery pain and inflammation. With twice-daily dosing, SURF-201 met its primary endpoints of absence of inflammation at both Day 8 and Day 15.
- Study: Implandata’s Eyemate System Protects Glaucoma Patients–Even During Lockdownhttps://modernod.com/news/study-implandatas-eyemate-system-protects-glaucoma-patients-even-during-lockdown/2478767/Patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand, these typically elderly, vulnerable individuals are often hampered in seeing their doctor for office visits, particularly durin
- Printable Chart Suitable for Stay-at-Home Visual Evaluationhttps://modernod.com/news/printable-chart-suitable-for-stay-at-home-visual-evaluation/2478763/A chart that can be downloaded or printed and mailed to patients appears effective in helping determine visual acuity via telephone assessments, according to researchers in the UK, Reuters reported. “We are excited to be deve
- CorNeat Vision’s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Centerhttps://modernod.com/news/corneat-visions-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center/2478741/The CorNeat KPro, an artificial cornea that integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor
- UK Officials Defend Contingency Plan to Mix COVID-19 Vaccines in Rare Caseshttps://modernod.com/news/uk-officials-defend-contingency-plan-to-mix-covid-19-vaccines-in-rare-cases/2478710/According to a guidance update on December 31, the UK government will allow people to be given doses of different COVID-19 vaccines under certain circumstances, despite a lack of evidence about the extent of immunity offered by such mixing. The issue has sparked criticism after a report in Th
- From COVID-19 to Retail Health: Fierce Healthcare’s Biggest Stories of 2020https://modernod.com/news/from-covid-19-to-retail-health-fierce-healthcares-biggest-stories-of-2020/2478689/The year 2020 was dominated by the fallout from a generational global pandemic. So perhaps it’s no surprise that COVID-19 headlines also governed much of